A鈭橶OL antifilarial drug discovery team
Winner: 2024 Chemistry Biology Interface Horizon Prize: Rita and John Cornforth Award
For the discovery of fast-acting, highly specific anti-Wolbachia candidates for the oral treatment of human filariasis.
Celebrate A鈭橶OL antifilarial drug discovery team
The A·WOL antifilarial drug discovery team is a collaboration between the University of Liverpool, Liverpool School of Tropical Medicine, Imperial College London, University of Bonn and industrial partners from Astra Zeneca and Eisai Ltd.
Read moreWe are delighted to receive this award for our collaborative research, which has allowed us to discover a first-in-class synthetic Anti-Wolbachia (AWOL) drug candidate against filarial diseases and a portfolio of distinctive fast-acting lead molecules for further chemical optimisation.
Q&A
Leave congratulations on this page
Please use this space to congratulate the winner, but note that the 新月直播app下载 will not respond to any comments or questions left on this page.
If you have a question or would like to get in touch with us, please contact us via this page.
Your comment will appear on this page after it is approved by moderators.
Fields marked with a '*' are mandatory.